CPI Aerostructures just delivered its first profitable quarter in over a year, yet the stock dropped 8% on the week — a gap between the fundamental print and the price action that is worth unpacking.
The Q1 numbers were genuinely better. Sales climbed to $17.36M from $15.4M a year ago. Net income flipped to $1.24M from a $1.32M loss. EPS came in at $0.09, versus a $0.10 loss in the year-prior period. That marks a clean earnings recovery after a full year 2025 that saw revenue shrink to $69.3M from $81.1M and a net loss of $0.84M. The reversal is real. The market, for now, is not paying up for it — CVU closed Friday at $3.65, down 2.7% on the day and 8% lower across the week.
Short interest is too small to explain the price pressure, but the intraday moves are worth noting. Estimated short interest jumped 355% in a single session on May 14 to roughly 88,600 shares, or 0.67% of the free float — a sharp one-day spike after a week in which shorts had actually been pulling back. The broader trend is more telling: estimated short interest has more than halved from April highs above 190,000 shares. The borrow market is nowhere near stressed. Cost to borrow is running at 1.79% — up 23% on the week but still firmly in cheap territory. The short score of 31 out of 100 sits in the 61st sector percentile, and with utilization of lending inventory at just 8.8% against a 52-week peak of 60.1%, there is ample room in the lending pool. This is not a crowded short.
Options positioning is structurally heavy on puts, but that is not unusual for CVU. The put/call ratio is 5.54, actually below the 20-day average of 6.09 and about one standard deviation below it, meaning options positioning has become marginally less defensive this week relative to recent norms. The 52-week PCR range runs from 0.13 to 7.10 — the current reading is toward the high end of the distribution in absolute terms, but the z-score of -1.06 says it has been notably more extreme in recent sessions.
The institutional picture is tightly held. The top shareholder on record, John Rudolf, controls 7.1% of shares outstanding. Royce & Associates added 25,000 shares in Q1 2026. Vanguard picked up a further 14,600 shares in the same period. None of these are large in dollar terms for the institutions involved, but for a stock with limited float and no active analyst coverage — the most recent rating changes on record predate 2021 and should be disregarded entirely — any sustained institutional accumulation matters. Insider activity is stale: the last logged trades date to mid-2025, and the 90-day net figure of $58K in net purchases is too small and too dated to draw conclusions from.
The next event to watch is the full transcript or any investor commentary following the May 21 scheduled event, where the May 15 Q1 print will be the reference point. The question the recovery quarter raises is whether the revenue growth rate — up 13% year-on-year — can hold into a defence budget environment where small aerostructures suppliers face pressure on contract timing and scope.
See the live data behind this article on ORTEX.
Open CVU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
